Literature DB >> 667582

Treatment of hypertensive emergencies with oral labetalol.

R R Ghose, Y B Mathur, M Upadhyay, W D Morgan, S Khan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 667582      PMCID: PMC1605848          DOI: 10.1136/bmj.2.6130.96

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  4 in total

1.  Pressor response after intravenous labetalol.

Authors:  M Crofton; R Gabriel
Journal:  Br Med J       Date:  1977-09-17

2.  Rapid onset of action of oral labetalol in severe hypertension.

Authors:  R R Ghose; A Sampson
Journal:  Curr Med Res Opin       Date:  1977       Impact factor: 2.580

3.  Labetalol in hypertension.

Authors: 
Journal:  Lancet       Date:  1977-05-28       Impact factor: 79.321

4.  Letter: Intravenous labetalol in severe hypertension.

Authors:  E A Rosei; P M Trust; J J Brown; A F Lever; J I Robertson
Journal:  Lancet       Date:  1975-11-29       Impact factor: 79.321

  4 in total
  9 in total

1.  Acute management of severe hypertension with oral labetalol.

Authors:  R R Ghose
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

2.  Labetalol in the treatment of patients with hypertension and renal function impairment.

Authors:  R R Bailey
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

Review 3.  Systemic and regional haemodynamic profile of diuretics and alpha- and beta-blockers. A review comparing acute and chronic effects.

Authors:  A Mimran; G Ducailar
Journal:  Drugs       Date:  1988       Impact factor: 9.546

Review 4.  Hypertensive emergencies and urgencies: definition, recognition, and management.

Authors:  J B Reuler; G J Magarian
Journal:  J Gen Intern Med       Date:  1988 Jan-Feb       Impact factor: 5.128

5.  Emergency treatment of high blood pressure with oral atenolol.

Authors:  L T Bannan; D G Beevers
Journal:  Br Med J (Clin Res Ed)       Date:  1981-05-30

6.  Labetalol in essential hypertension.

Authors:  A Breckenridge; M Orme; M J Serlin; M Maciver
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335

Review 7.  Pharmacology of combined alpha-beta-blockade. I.

Authors:  W J Louis; J J McNeil; O H Drummer
Journal:  Drugs       Date:  1984       Impact factor: 9.546

8.  Monotherapy with labetalol for hypertensive patients with normal and impaired renal function.

Authors:  F D Thompson; A M Joekes; M M Hussein
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

9.  Hypertensive crisis treated with orally administered captopril.

Authors:  J Biollaz; B Waeber; H R Brunner
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.